A phase 1 study of concurrent late course accelerated hyper-fractionated radiotherapy and capecitabine and cisplatin for local advanced esophageal cancer

被引:2
|
作者
Li, B. [1 ]
Yan, J. [1 ]
Zhou, T. [1 ]
Wang, Z. [1 ]
Li, H. [1 ]
Sun, H. [1 ]
机构
[1] Shandong Tumor Hosp, Jinan, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词
D O I
10.1016/j.ijrobp.2008.06.1744
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S283 / S283
页数:1
相关论文
共 50 条
  • [1] Phase 1 study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma
    Li, Bao-sheng
    Zhou, Tao
    Wang, Zhong-tang
    Li, Hong-sheng
    Sun, Hong-fu
    Zhang, Zhi-cheng
    Lin, Hai-qun
    Wei, Yu-mei
    Gong, He-yi
    Huang, Wei
    Yi, Yan
    Wang, Li-ying
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 458 - 461
  • [2] Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma
    Li, B-S.
    Gong, H-Y.
    Huang, W.
    Yi, Y.
    Zhang, Z-C.
    Li, H-S.
    Wang, Z-T.
    Yu, J-M.
    DISEASES OF THE ESOPHAGUS, 2011, 24 (04) : 251 - 257
  • [3] Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma
    Li, B.
    Gong, H.
    Huang, W.
    Yi, Y.
    Zhang, Z.
    Li, H.
    Wang, Z.
    Sun, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 370 - 371
  • [4] Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma
    Fu, C.
    Li, B.
    Guo, L.
    Li, H.
    Huang, W.
    Gong, H.
    Sun, M.
    Wang, Z.
    Zhou, T.
    Liu, C.
    BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1037):
  • [5] Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study
    Wang, Dongqing
    Yang, Jiali
    Zhu, Jingyu
    Li, Baosheng
    Zhai, Limin
    Sun, Mingping
    Gong, Heyi
    Zhou, Tao
    Wei, Yumei
    Huang, Wei
    Wang, Zhongtang
    Li, Hongsheng
    Zhang, Zicheng
    RADIATION ONCOLOGY, 2013, 8
  • [6] Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study
    Dongqing Wang
    Jiali Yang
    Jingyu Zhu
    Baosheng Li
    Limin Zhai
    Mingping Sun
    Heyi Gong
    Tao Zhou
    Yumei Wei
    Wei Huang
    Zhongtang Wang
    Hongsheng Li
    Zicheng Zhang
    Radiation Oncology, 8
  • [7] Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer
    Maemura, Kosei
    Mataki, Yuko
    Kurahara, Hiroshi
    Kawasaki, Yota
    Iino, Satoshi
    Sakoda, Masahiko
    Ueno, Shinichi
    Arimura, Takeshi
    Higashi, Ryutaro
    Yoshiura, Takashi
    Shinchi, Hiroyuki
    Natsugoe, Shoji
    PANCREATOLOGY, 2017, 17 (05) : 833 - 838
  • [8] Long-term outcomes of late course accelerated hyper-fractionated radiotherapy for localized esophageal carcinoma in Mainland China: a meta-analysis
    Zhang, Y. W.
    Chen, L.
    Bai, Y.
    Zheng, X.
    DISEASES OF THE ESOPHAGUS, 2011, 24 (07) : 495 - 501
  • [9] Result of accelerated hyper-fractionated pelvic radiation in locally advanced inoperable rectal cancer
    Ghoshdastidar, A.
    Saha, S.
    Gupta, P.
    Kundu, S.
    Ghosh, K.
    Ray, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 71 - 71
  • [10] Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcittabine for unresectable pancreatic cancer
    Maemura, Kosei
    Shinchi, Hiroyuki
    Noma, Hidetoshi
    Mataki, Yuko
    Kurahara, Hiroshi
    Maeda, Shinichi
    Hiraki, Yoshiyuki
    Nakajo, Masayuki
    Natsugoe, Shoji
    Takao, Sonshin
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2369 - 2372